164 related articles for article (PubMed ID: 18050612)
1. [Search for the etiopathogenesis of polycystic ovary syndrome (PCOS)].
Wertheim K; Sobczyńska-Tomaszewska A; Bal J
Ginekol Pol; 2007 Aug; 78(8):626-31. PubMed ID: 18050612
[TBL] [Abstract][Full Text] [Related]
2. [Genetic aspects of polycystic ovary syndrome].
Jakubowski L
Endokrynol Pol; 2005; 56(3):285-93. PubMed ID: 16350721
[TBL] [Abstract][Full Text] [Related]
3. Polycystic ovary syndrome susceptibility single nucleotide polymorphisms in women with a single PCOS clinical feature.
Cui L; Li G; Zhong W; Bian Y; Su S; Sheng Y; Shi Y; Wei D; Zhang W; Zhao H; Chen ZJ
Hum Reprod; 2015 Mar; 30(3):732-6. PubMed ID: 25586784
[TBL] [Abstract][Full Text] [Related]
4. The role of polymorphism in various potential genes on polycystic ovary syndrome susceptibility and pathogenesis.
Chaudhary H; Patel J; Jain NK; Joshi R
J Ovarian Res; 2021 Sep; 14(1):125. PubMed ID: 34563259
[TBL] [Abstract][Full Text] [Related]
5. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
[TBL] [Abstract][Full Text] [Related]
6. The role of genes in the polycystic ovary syndrome: predisposition and mechanisms.
Deligeoroglou E; Kouskouti C; Christopoulos P
Gynecol Endocrinol; 2009 Sep; 25(9):603-9. PubMed ID: 19591017
[TBL] [Abstract][Full Text] [Related]
7. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature.
Azziz R
J Clin Endocrinol Metab; 2006 Mar; 91(3):781-5. PubMed ID: 16418211
[TBL] [Abstract][Full Text] [Related]
8. [The role of leptin in polycystic ovary syndrome].
Marciniak A; Starczewski A
Pol Merkur Lekarski; 2008 Oct; 25(148):390-3. PubMed ID: 19145943
[TBL] [Abstract][Full Text] [Related]
9. [Polymorphism in CYP11alpha and CYP17 genes and the etiology of hyperandrogenism in patients with polycystic ovary syndrome].
Pérez MS; Cerrone GE; Benencia H; Márquez N; De Piano E; Frechtel GD
Medicina (B Aires); 2008; 68(2):129-34. PubMed ID: 18499961
[TBL] [Abstract][Full Text] [Related]
10. A genetic risk score is associated with polycystic ovary syndrome-related traits.
Lee H; Oh JY; Sung YA; Chung HW
Hum Reprod; 2016 Jan; 31(1):209-15. PubMed ID: 26573528
[TBL] [Abstract][Full Text] [Related]
11. Basic research in PCOS: are we reaching new frontiers?
Ben-Shlomo I; Younis JS
Reprod Biomed Online; 2014 Jun; 28(6):669-83. PubMed ID: 24768413
[TBL] [Abstract][Full Text] [Related]
12. Polycystic ovaries are inherited as an autosomal dominant trait: analysis of 29 polycystic ovary syndrome and 10 control families.
Govind A; Obhrai MS; Clayton RN
J Clin Endocrinol Metab; 1999 Jan; 84(1):38-43. PubMed ID: 9920059
[TBL] [Abstract][Full Text] [Related]
13. PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors.
Broekmans FJ; Knauff EA; Valkenburg O; Laven JS; Eijkemans MJ; Fauser BC
BJOG; 2006 Oct; 113(10):1210-7. PubMed ID: 16972863
[TBL] [Abstract][Full Text] [Related]
14. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
15. Association of the 17-hydroxysteroid dehydrogenase type 5 gene polymorphism (-71A/G HSD17B5 SNP) with hyperandrogenemia in polycystic ovary syndrome (PCOS).
Marioli DJ; Saltamavros AD; Vervita V; Koika V; Adonakis G; Decavalas G; Markou KB; Georgopoulos NA
Fertil Steril; 2009 Aug; 92(2):648-52. PubMed ID: 18692800
[TBL] [Abstract][Full Text] [Related]
16. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype.
Legro RS; Chiu P; Kunselman AR; Bentley CM; Dodson WC; Dunaif A
J Clin Endocrinol Metab; 2005 May; 90(5):2571-9. PubMed ID: 15713728
[TBL] [Abstract][Full Text] [Related]
17. Genotype-phenotype correlations of PCOS susceptibility SNPs identified by GWAS in a large cohort of Han Chinese women.
Cui L; Zhao H; Zhang B; Qu Z; Liu J; Liang X; Zhao X; Zhao J; Sun Y; Wang P; Li T; Shi Y; Chen ZJ
Hum Reprod; 2013 Feb; 28(2):538-44. PubMed ID: 23208300
[TBL] [Abstract][Full Text] [Related]
18. Increased frequency of the DI genotype of the angiotensin-I converting enzyme and association of the II genotype with insulin resistance in polycystic ovary syndrome.
Koika V; Georgopoulos NA; Piouka A; Roupas ND; Karela A; Armeni AK; Katsantoni E; Panidis D
Eur J Endocrinol; 2012 Apr; 166(4):695-702. PubMed ID: 22223701
[TBL] [Abstract][Full Text] [Related]
19. Perspectives in Polycystic Ovary Syndrome: From Hair to Eternity.
Dunaif A
J Clin Endocrinol Metab; 2016 Mar; 101(3):759-68. PubMed ID: 26908109
[TBL] [Abstract][Full Text] [Related]
20. Pro12Ala and His447His polymorphisms of PPAR-gamma are associated with polycystic ovary syndrome.
Gu BH; Baek KH
Reprod Biomed Online; 2009 May; 18(5):644-50. PubMed ID: 19549442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
